Doctopsy

Paris, France Founded: 2016 • Age: 10 yrs Acquired By Qare
Online teleconsultation platform for psychiatric and nutritional appointments is offered.
Request Access

About Doctopsy

Doctopsy is a company based in Paris (France) founded in 2016 by Benjamin Maquet and Fanny Jacq was acquired by Qare in June 2020.. Doctopsy has raised $2.32 million across 1 funding round from investors including Qare, Bpifrance and ELSAN. Doctopsy operates in a competitive market with competitors including Concilio, MEDADOM, MesDocteurs, Medicitus and Medihere, among others.

  • Headquarter Paris, France
  • Founders Benjamin Maquet, Fanny Jacq
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.32 M (USD)

    in 1 rounds

  • Latest Funding Round
    $2.32 M (USD), Seed

    Sep 17, 2018

  • Investors
    Qare

    & 2 more

  • Employee Count
    Employee Count
  • Acquired by
    Qare

    (Jun 01, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Doctopsy

Doctopsy has successfully raised a total of $2.32M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.32 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $2.3M
  • First Round

    (17 Sep 2018)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2018 Amount Seed - Doctopsy Valuation Elsan , Bpifrance
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Doctopsy

Doctopsy has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Qare, Bpifrance and ELSAN. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
A chain of multi-speciality hospitals is operated across France.
Founded Year Domain Location
Corporate consultancy, advisory, and funding services are provided to businesses.
Founded Year Domain Location
Telemedicine consultations are offered across 12 medical specialties via video.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Doctopsy

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Doctopsy

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Doctopsy Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Doctopsy

Doctopsy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Concilio, MEDADOM, MesDocteurs, Medicitus and Medihere, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Online platform offering telemedicine services
domain founded_year HQ Location
App for online and home based consultation
domain founded_year HQ Location
Teleconsultation platform with booking and multi-mode consultations is provided.
domain founded_year HQ Location
Appointments with doctors are booked via an online platform.
domain founded_year HQ Location
Provider of an app for virtual primary care and tele-medicine
domain founded_year HQ Location
Mobile telemedicine platform for emergency treatments
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Doctopsy

Frequently Asked Questions about Doctopsy

When was Doctopsy founded?

Doctopsy was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Where is Doctopsy located?

Doctopsy is headquartered in Paris, France.

Who is the current CEO of Doctopsy?

Fanny Jacq is the current CEO of Doctopsy. They have also founded this company.

Is Doctopsy a funded company?

Doctopsy is a funded company, having raised a total of $2.32M across 1 funding round to date. The company's 1st funding round was a Seed of $2.32M, raised on Sep 17, 2018.

What does Doctopsy do?

Doctopsy was founded in 2016 in Paris, France, as a healthcare technology provider. An online platform is operated to enable patient appointments for teleconsultations or in-person sessions with psychiatrists, child psychiatrists, nutritionists, and addictologists. Access to these specialized services is facilitated through the domain doctopsy.com, focusing on mental health and wellness support in the European market.

Who are the top competitors of Doctopsy?

Doctopsy's top competitors include MEDADOM, Concilio and MesDocteurs.

Who are Doctopsy's investors?

Doctopsy has 3 investors. Key investors include Qare, Bpifrance, and ELSAN.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available